Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

When researchers announced two years ago that they had found a way to turn ordinary skin cells into stem cells, it opened up the possibility that stem cell therapies might sidestep the logistical and ethical hurdles of obtaining stem cells from embryos. These “reprogrammed” stem cells seem to have the ability to transform into any kind of cell, a property known as pluripotency. But the concept has also met with skepticism about the abilities and potential dangers of the cells. A new study in the Proceedings of the National Academy of Sciences by scientists at MIT and Harvard shows that reprogrammed cells, also called induced pluripotent stem (iPS) cells, can become functioning neurons when transplanted into the brains of mice and rats; the researchers also showed that the cells can improve symptoms in a rat model of Parkinson’s disease.

The research team, led by Rudolph Jaenisch at the Whitehead Institute for Biomedical Research at MIT, used the previously developed method for reprogramming cells, in which skin cells of a mouse can be made pluripotent when infected with a retrovirus carrying four genes. First, the scientists showed that they could turn mouse skin cells into functioning neurons in culture. They then transplanted these neurons into the brains of mice while they were still fetuses. After the mice grew into early adulthood, the researchers examined the brains and identified the transplanted cells, which had been labeled with a fluorescent marker. The cells “migrate nicely into the brain and mature in the brain,” says Marius Wernig, a postdoctoral fellow at the Whitehead Institute. “They adopt functions of mature neurons.”

Next, the group tested whether these functioning neurons could repair a defect in an animal model of disease. Parkinson’s involves a loss of a specific population of neurons—-those that produce dopamine. The study used a model for Parkinson’s in which rats are given a toxin that kills dopamine neurons on one side of the brain. Although the animals appear normal, when their dopamine neurons are stimulated with amphetamine, they begin to turn in circles in the direction of the damaged side. In rats that were given transplants of neurons derived from iPS cells, the motor defect improved.

John Gearhart, a stem cell biologist at Johns Hopkins School of Medicine who was not involved in the study, says that previous studies with the reprogrammed cells have had conflicting results–some studies show that the cells have similar abilities as embryonic stem cells, while others don’t. “This is an important study,” says Gearhart, because it compares the iPS cells with neurons derived from embryonic stem cells.

4 comments. Share your thoughts »

Credit: National Academy of Sciences, PNAS.

Tagged: Biomedicine, MIT, stem cells, Parkinson's, reprogramming cells, skin cells

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me